Executive Summary
The Swiss Federal Council adopted the mandate for the Swiss delegation to the 17th World Biodiversity Conference (CBD COP17) on 24 June 2026. The conference will take place from 19 to 31 October 2026 in Yerevan, Armenia. The focus is on implementing the global Kunming-Montreal Biodiversity Framework and conducting an initial interim assessment of progress to date. The Federal Council has also adopted the second phase (2025–2030) of the action plan for the Swiss Biodiversity Strategy.
People
- Katrin Schneeberger (Director Federal Office for the Environment, FOEN)
- Felix Wertli (Environmental Ambassador, alternate representative)
Topics
- Biodiversity conferences
- International environmental policy
- Genetic resources
- Swiss climate policy
Clarus Lead
CBD COP17 marks a critical evaluation point: for the first time, the global community will assess whether national biodiversity strategies comply with the ambitious goals of the Kunming-Montreal Framework. Switzerland positions itself as an advocate for scientifically-based assessments and practical solutions in regulating digitalized genetic sequence information – a topic with direct implications for pharmaceutical research and the biotech industry.
Detailed Summary
The conference will conduct a comprehensive analysis that is not only based on government reports, but also incorporates findings from the Intergovernmental Science-Policy Platform on Biodiversity and Ecosystem Services and contributions from international organizations. This is intended to provide a complete picture of the state of fauna, flora and ecosystems and identify gaps in implementation to date.
A central negotiation focus concerns access to genetic resources and their distribution. Switzerland advocates for a mechanism that provides legal certainty when using digitalized genetic sequence information without hindering research activities. At the same time, revenues from genetic resources should benefit biodiversity conservation. Switzerland also seeks enhanced coordination between various biodiversity-relevant international conventions.
Key Messages
- The Federal Council strengthens Swiss engagement through the second phase of the Biodiversity Action Plan (2025–2030)
- First global interim assessment on implementation of the Kunming-Montreal Framework is being conducted
- Switzerland focuses on practical regulations for digitalized genetic sequence information without research obstacles
Critical Questions
Evidence Quality: What indicators does the global assessment use to measure biodiversity loss, and how comparable are national data standards?
Conflicts of Interest: To what extent do pharmaceutical and biotech lobby interests influence Switzerland's position on genetic sequence information, and how is transparency ensured?
Causality: Can it be demonstrated that national biodiversity strategies actually lead to measurable improvements, or do external factors dominate (climate change, land use)?
Feasibility: How will the goals of the 2025–2030 action plan be operationalized with limited budget resources, and what sanctions mechanisms exist if targets are missed?
Counter-Hypotheses: Could decentralized national regulation be more effective than a global framework with varying implementation capacities?
Sources
Primary Source: Swiss Federal Council – Press Release: «Biodiversity: Federal Council adopts second phase of action plan» – https://www.news.admin.ch/de/newnsb/0UMOvP1fwO1SRJEF2c3mN
Verification Status: ✓ 24.06.2026
This text was created with the support of an AI model. Editorial responsibility: clarus.news | Fact-checking: 24.06.2026